Clinical Trial Update: 4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

A Phase 2 crossover trial comparing Combivent CFC to albuterol, followed by open-label Combivent Respimat for rescue therapy in adults with moderate-to-severe a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol (albuterol)
• Combivent CFC (ipratropium bromide and albuterol)
• Combivent Respimat (ipratropium bromide and albuterol sulfate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2010-11-23